"Designing Growth Strategies is in our DNA"
The global endoscopic submucosal dissection market is experiencing significant growth due to the increasing demand for cancer removal surgeries in the gastrointestinal tract and advancements in endoscopic submucosal dissection devices and accessories, which are expected to support its adoption in the forthcoming years. As a result, key players are expanding their product portfolios and reach in both developed and developing countries worldwide.
Rising Incidence of Gastrointestinal (GI) Cancers to Propel the Market Growth
Over the past few years, there has been a rise in the incidence of gastrointestinal cancers globally. This is driving the increase in screening and early-detection programs, which in turn is fueling the demand for minimally invasive treatments such as endoscopic submucosal dissection (ESD). These procedures shorten the recovery period compared to open surgery, which is driving their adoption and spurring market growth.
Download Free sample to learn more about this report.
According to data published by the American Cancer Society, Inc., around 107,320 new cases of colon cancer were reported in 2025.
Shortage of Skilled Professionals to Hinder the Market Growth
ESD procedures require advanced endoscopic skills, precise control, deep knowledge of GI tract anatomy, and experience, particularly for the colon and esophagus. In several emerging and low-income countries, there is a shortage of such professionals, leading to delays that limit procedure volumes and restrict market growth.
Increasing Adoption of ESC in Developing Regions to Offer Lucrative Growth Opportunity
In recent years, there has been a growing adoption of ESD in developing countries, including India, China, Brazil, and South Korea. Improvements in healthcare infrastructure and a rising awareness of ESD among clinicians in these countries support this. Such a scenario is anticipated to offer lucrative opportunities for key players to expand their product offerings in these countries.
|
By Product Type |
By Indication |
By End-user |
By Geography |
|
|
|
· North America (U.S. and Canada) · Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and the Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific) · Latin America (Brazil, Mexico, and the Rest of Latin America) · Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa) |
The report covers the following key insights:
Based on product type, the market is fragmented into gastroscopes & colonoscopes, knives, injection agents, tissue retractors, graspers/clips, and others.
The gastroscopes & colonoscopes segment is expected to account for the largest market share during the forecast period. Gastroscopes & colonoscopes are primary capital equipment required for every ESD procedure. Their demand is driven by upgrades from standard to high-resolution or magnification scopes. In response, hospitals are replacing aging systems, expanding endoscopy units and adding ESD capabilities.
By indication, the market is categorized into colon cancer, esophageal cancer, stomach cancer, and others.
The diagnostics segment is expected to hold a significant share during the forecast period. In East Asia, the early gastric cancer screening is significantly higher. Moreover, the high en bloc resection rates and excellent outcomes are driving strong adoption of ESD, which is anticipated to drive the segment’s growth during the forecast period.
By end-user, the market is segmented into hospitals & ASCs, specialty clinics, and others.
The hospitals & ASCs segment held the largest market share in 2025. The growth is due to the high volume of endoscopic submucosal procedures performed in hospitals as well as ASCs. Moreover, the significant growth in the number of ASCs is also contributing to this increasing volume, driving the adoption of ESD devices.
Request for Customization to gain extensive market insights.
On the basis of geography, the market has been studied across Europe, North America, Latin America, Asia Pacific, and the Middle East & Africa.
North America held the largest global endoscopic submucosal dissection market share in 2025. The growth is attributed to the high incidence of GI cancer surgery in the region, which contributes to the high adoption of ESD devices. Moreover, the availability of major players in the U.S. and Canada is additionally contributing to the high penetration of these devices in the region.
Asia Pacific is expected to grow at the highest CAGR over the forecast period. The growth is attributed to the focus of key players on opening new manufacturing sites in the region, driven by the high incidence of GI cancers. Moreover, the increasing aging population and high smoking rate are increasing the prevalence of such cancers in the region, driving ESD surgery volumes.
The global endoscopic submucosal dissection market is fragmented, with key companies focusing on expanding their product reach globally through partnerships, collaborations, and launches, which is expected to help them gain a significant share of the market.
The report includes the profiles of the following key players:
Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )